- Home
- ZNTL vs EU Comparison
ZNTL vs EU Comparison
Compare ZNTL & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZNTL | EU |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 313.9M | 361.2M |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ZNTL | EU |
|---|---|---|
| Price | $4.06 | $1.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $6.60 | $4.00 |
| AVG Volume (30 Days) | 1.0M | ★ 2.7M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.03 | 11.76 |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $43,155,000.00 |
| Revenue This Year | N/A | $212.11 |
| Revenue Next Year | N/A | $29.88 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.13 | $1.34 |
| 52 Week High | $6.95 | $4.19 |
Technical Indicators
Market Signals| Indicator | ZNTL | EU |
|---|---|---|
| Relative Strength Index (RSI) | 51.88 | 35.08 |
| Support Level | $3.75 | N/A |
| Resistance Level | $4.40 | $2.83 |
| Average True Range (ATR) | 0.32 | 0.11 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 59.20 | 22.83 |
Price Performance
Historical ComparisonAbout ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is principally engaged in the acquisition, exploration, development and extraction of uranium resource properties in the United States. The Company is focused on the extraction of domestic uranium in the United States. The Company utilizes the In-Situ Recovery technology (ISR) to provide necessary fuel for the generation of clean, reliable, and carbon-free nuclear energy.